
Spanish dermatology firm Almirall is launching Wynzora, a plaque psoriasis cream developed by Danish firm MC2 Therapeutics, in Denmark, the firm has announced in a press release.
Almirall was granted European licensing rights to Wynzora last year, and has already launched the treatment in Germany, Spain and the UK earlier this year.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app